Display options
Cite
Johansen A, Lomsky M, Gerke O, et al. When is reacquisition necessary due to high extra-cardiac uptake in myocardial perfusion scintigraphy?. EJNMMI Res. 2013;3(1):20doi: 10.1186/2191-219X-3-20.
Johansen, A., Lomsky, M., Gerke, O., Edenbrandt, L., Johansson, L., Hansen, G., Jensen, B., Reid, M. S., Johansson, L. L., Olofsson, C., Minarik, D., Nyström, K., Wollmer, P., & Trägårdh, E. (2013). When is reacquisition necessary due to high extra-cardiac uptake in myocardial perfusion scintigraphy?. EJNMMI research, 3(1), 20. https://doi.org/10.1186/2191-219X-3-20
Johansen, Allan, et al. "When is reacquisition necessary due to high extra-cardiac uptake in myocardial perfusion scintigraphy?." EJNMMI research vol. 3,1 (2013): 20. doi: https://doi.org/10.1186/2191-219X-3-20
Johansen A, Lomsky M, Gerke O, Edenbrandt L, Johansson L, Hansen G, Jensen B, Reid MS, Johansson LL, Olofsson C, Minarik D, Nyström K, Wollmer P, Trägårdh E. When is reacquisition necessary due to high extra-cardiac uptake in myocardial perfusion scintigraphy?. EJNMMI Res. 2013 Mar 25;3(1):20. doi: 10.1186/2191-219X-3-20. PMID: 23521849; PMCID: PMC3614539.
Copy Download .nbib Format: NLM
Share it on

EJNMMI Res. 2013 Mar 25;3(1):20. doi: 10.1186/2191-219X-3-20.

When is reacquisition necessary due to high extra-cardiac uptake in myocardial perfusion scintigraphy?.

EJNMMI research

Allan Johansen, Milan Lomsky, Oke Gerke, Lars Edenbrandt, Lena Johansson, Gunhild Hansen, Birgitte Jensen, Maria Sallerup Reid, Lise-Lott Johansson, Camilla Olofsson, David Minarik, Karin Nyström, Per Wollmer, Elin Trägårdh

Affiliations

  1. Nuclear Medicine Unit, Skåne University Hospital, Lund University, Malmo, Sweden. [email protected].

PMID: 23521849 PMCID: PMC3614539 DOI: 10.1186/2191-219X-3-20

Abstract

BACKGROUND: Technetium-labeled agents, which are most often used for assessing myocardial perfusion in myocardial perfusion scintigraphy (MPS), are cleared by the liver and excreted by the biliary system. Spillover from extra-cardiac activity into the myocardium, especially the inferior wall, might conceal defects and lower the diagnostic accuracy of the study. The objective was to determine rules of thumb for when reacquisition is useful due to high extra-cardiac uptake, i.e., when interpretation of the studies was affected by poor image quality.

METHODS: Patients admitted to MPS at any of the three study sites, who also underwent a reacquisition due to high extra-cardiac uptake were included. Image quality was assessed by ten technologists on a scale ranging from 1 to 5. Interpretations regarding the presence/absence of ischemia/infarction, including the certainty of the diagnosis, were made by three physicians.

RESULTS: There was a statistically significant increase in image quality between the first and the repeated acquisition (1,256 cases of increased quality at the repeated study (66%), 134 cases of decreased quality at the repeated study (7%), 510 cases of unchanged quality (27%) P < 0.0001). The number of equivocal studies, interpreted by physicians, decreased when evaluating the repeated studies compared to the first studies for all physicians, both for the interpretations of ischemia and for infarction. Receiver operating characteristic analyses revealed that for both endpoints (ischemia, infarction) and all physicians, the optimal cutoff point for performing a reacquisition was between quality categories 2 and 3.

CONCLUSION: This study indicates that repeat acquisition is useful when (1) the intensity of the extra-cardiac uptake is equal to or higher than the cardiac uptake when there is no separation between the extra-cardiac uptake and the inferior cardiac wall and (2) when the intensity of the extra-cardiac uptake is higher than the cardiac uptake when there is a separation between the extra-cardiac uptake and the inferior wall of less than one cardiac wall.

References

  1. Eur Heart J. 2011 Apr;32(8):1012-24 - PubMed
  2. J Nucl Cardiol. 1996 Jan-Feb;3(1):18-29 - PubMed
  3. Circulation. 1996 Mar 1;93(5):905-14 - PubMed
  4. J Am Coll Cardiol. 1996 Jul;28(1):34-44 - PubMed
  5. Nucl Med Commun. 2008 Sep;29(9):759-63 - PubMed
  6. J Nucl Med. 1994 Feb;35(2):356-9 - PubMed
  7. J Nucl Med. 2007 Oct;48(10):1670-5 - PubMed
  8. Biometrics. 1977 Mar;33(1):159-74 - PubMed
  9. J Am Coll Cardiol. 1998 Jul;32(1):57-62 - PubMed
  10. J Nucl Med Technol. 2006 Dec;34(4):193-211; quiz 212-4 - PubMed
  11. J Nucl Med. 1997 Dec;38(12):1882-90 - PubMed
  12. Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):855-97 - PubMed
  13. Biometrics. 1997 Sep;53(3):823-37 - PubMed

Publication Types